SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/DDCF614CD4F13E01B078714E7984DF93D444A4C832F834CD28CA9164BC2B536ED261EF8B0DEC8ADE3B9BFB627F1060AB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/DDCF614CD4F13E01B078714E7984DF93D444A4C832F834CD28CA9164BC2B536ED261EF8B0DEC8ADE3B9BFB627F1060AB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/DDCF614CD4F13E01B078714E7984DF93D444A4C832F834CD28CA9164BC2B536ED261EF8B0DEC8ADE3B9BFB627F1060AB
http://www.w3.org/2000/01/rdf-schema#comment
"We present two cases of metastatic melanoma treated with nivolumab and pembrolizumab (anti PD-1). Both patients developed acute interstitial nephritis during immune checkpoint therapy"
xsd:string
http://purl.uniprot.org/uniprot/#_FBB71DF1B8B6E31F28AF704F488D44EFFEBAE5577EF64C37A82DCC9A9886EF3895DE9CAE35E25FC0318AB966BA4BC9CC
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/DDCF614CD4F13E01B078714E7984DF93D444A4C832F834CD28CA9164BC2B536ED261EF8B0DEC8ADE3B9BFB627F1060AB
http://purl.uniprot.org/uniprot/A0A0M3M0G7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/DDCF614CD4F13E01B078714E7984DF93D444A4C832F834CD28CA9164BC2B536ED261EF8B0DEC8ADE3B9BFB627F1060AB
http://purl.uniprot.org/uniprot/#_A0A0M3M0G7-mappedCitation-28105370
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/DDCF614CD4F13E01B078714E7984DF93D444A4C832F834CD28CA9164BC2B536ED261EF8B0DEC8ADE3B9BFB627F1060AB